![Jonathan-Javitt-NRx Jonathan Javitt](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/Jonathan-Javitt-NRx-500x300.jpg)
NRx
![Jonathan-Javitt-NRx Jonathan Javitt](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/Jonathan-Javitt-NRx-500x300.jpg)
![NRx HTX-100 IV ketamine](https://psychedelicmedicalnews.com/wp-content/uploads/2024/04/NRx-HTX-101-500x300.jpg)
NRx Says New Formulation of IV Ketamine Could Be Delivered Subcutaneously
![NRX-101 NRX-101](https://psychedelicmedicalnews.com/wp-content/uploads/2024/04/NRX-101-500x300.jpg)
NRx Pharmaceuticals Achieves Data Lock in Phase 2B/3 Trial of NRX-101
![NRx-Data-Sharing NRx Data Sharing Columbia](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/NRx-Data-Sharing-500x300.jpg)
NRx Announces Data-Sharing Agreement with Columbia University for Results from IV Ketamine Trial
![Jonathan-Javitt-NRx Jonathan Javitt](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/Jonathan-Javitt-NRx-500x300.jpg)
NRx Pharmaceuticals Founder Jonathan Javitt Discusses Company’s Mission, Pipeline in Nasdaq Interview
![Ketamine. Dissociative ketamine. Chemical formula, molecular structure. Ilustration background for your desigen. Disoviative drugs. Ketamin banner. Ketamine. Dissociative ketamine. Chemical formula, molecular structure. Ilustration background for your desigen. Disoviative drugs. Ketamin banner.](https://psychedelicmedicalnews.com/wp-content/uploads/2023/11/Depositphotos_616738402_L-1024x662-500x300.jpg)